{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:56Z","timestamp":1772166596003,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T00:00:00Z","timestamp":1665273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T00:00:00Z","timestamp":1665273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"VTR Finnish Government Funding"},{"DOI":"10.13039\/501100003406","name":"Tekes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Finnish Cancer Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Allogeneic therapeutic cells may be rejected if they express HLA alleles not found in the recipient. As finding cell donors with a full HLA match to a recipient requires vast donor pools, the use of HLA homozygous cells has been suggested as an alternative. HLA homozygous cells should be well tolerated by those who carry at least one copy of donor HLA alleles. HLA-A-B homozygotes could be valuable for HLA-matched thrombocyte products. We evaluated the feasibility of blood donor biobank and HLA imputation for the identification of potential cell donors homozygous for HLA alleles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We imputed HLA-A, -B, -C, -DRB1, -DQA1, -DQB1 and -DPB1 alleles from genotypes of 20,737 Finnish blood donors in the Blood Service Biobank. We confirmed homozygosity by sequencing HLA alleles in 30 samples and by examining 36,161 MHC-located polymorphic DNA markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three hundred and seventeen individuals (1.5%), representing 41 different haplotypes, were found to be homozygous for HLA-A, -B, -C, -DRB1, -DQA1 and -DQB1 alleles. Ten most frequent haplotypes homozygous for HLA-A to -DQB1 were HLA-compatible with 49.5%, and three most frequent homozygotes to 30.4% of the Finnish population. Ten most frequent HLA-A-B homozygotes were compatible with 75.3%, and three most frequent haplotypes to 42.6% of the Finnish population. HLA homozygotes had a low level of heterozygosity in MHC-located DNA markers, in particular in HLA haplotypes enriched in Finland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study shows that HLA imputation in a blood donor biobank of reasonable size can be used to identify HLA homozygous blood donors suitable for cell therapy, HLA-typed thrombocytes and research. The homozygotes were HLA-compatible with a large fraction of the Finnish population. Regular blood donors reported to have positive attitude to research donation appear a good option for these purposes. Differences in population frequencies of HLA haplotypes emphasize the need for population-specific collections of HLA homozygous samples.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-022-03182-7","type":"journal-article","created":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T18:02:30Z","timestamp":1665338550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Blood donor biobank and HLA imputation as a resource for HLA homozygous cells for therapeutic and research use"],"prefix":"10.1186","volume":"13","author":[{"given":"Jonna","family":"Clancy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Hyv\u00e4rinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Ritari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Wahlfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-4734","authenticated-orcid":false,"given":"Jukka","family":"Partanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satu","family":"Koskela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,9]]},"reference":[{"key":"3182_CR1","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105:3051\u20137.","journal-title":"Blood"},{"key":"3182_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00233","volume":"5","author":"GM Pigeau","year":"2018","unstructured":"Pigeau GM, Csaszar E, Dulgar-Tulloch A. Commercial scale manufacturing of allogeneic cell therapy. Front Med. 2018;5:1\u20138.","journal-title":"Front Med"},{"key":"3182_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbmt.2006.12.447","volume":"13","author":"AT Badillo","year":"2007","unstructured":"Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant. 2007;13:412\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"key":"3182_CR4","doi-asserted-by":"crossref","unstructured":"Sullivan S, Fairchild PJ, Marsh SGE, M\u00fcller CR, Turner ML, Song J, et al. Haplobanking induced pluripotent stem cells for clinical use. Stem Cell Res [Internet]. 2020;49:102035. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506120303366","DOI":"10.1016\/j.scr.2020.102035"},{"key":"3182_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s40778-015-0011-7","volume":"1","author":"J Barry","year":"2015","unstructured":"Barry J, Hyllner J, Stacey G, Taylor CJ, Turner M. Setting up a haplobank: issues and solutions. Curr Stem Cell Reports. 2015;1:110\u20137.","journal-title":"Curr Stem Cell Reports"},{"key":"3182_CR6","first-page":"791","volume":"129","author":"PJ Martin","year":"2018","unstructured":"Martin PJ, Levine DM, Storer BE, Warren EH, Zheng X, Nelson SC, et al. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood J Am Soc Hematol. 2018;129:791\u20139.","journal-title":"Blood J Am Soc Hematol"},{"key":"3182_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2012-03-379032","volume":"120","author":"SR Spellman","year":"2012","unstructured":"Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, et al. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120:259\u201365.","journal-title":"Blood"},{"key":"3182_CR8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(05)67813-0","volume":"366","author":"CJ Taylor","year":"2005","unstructured":"Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet Elsevier. 2005;366:2019\u201325.","journal-title":"Lancet Elsevier"},{"key":"3182_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nbt0708-739","volume":"26","author":"N Nakatsuji","year":"2008","unstructured":"Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol. 2008;26:739\u201340.","journal-title":"Nat Biotechnol"},{"key":"3182_CR10","doi-asserted-by":"crossref","unstructured":"Lee S, Huh JY, Turner DM, Lee S, Robinson J, Stein JE, et al. Repurposing the cord blood bank for haplobanking of HLA-homozygous iPSCs and their usefulness to multiple populations. Stem Cells [Internet]. 2018;36:1552\u201366. Available from: https:\/\/academic.oup.com\/stmcls\/article\/36\/10\/1552-1566\/6423921","DOI":"10.1002\/stem.2865"},{"key":"3182_CR11","doi-asserted-by":"crossref","unstructured":"Pappas DJ, Gourraud P-A, Le Gall C, Laurent J, Trounson A, DeWitt N, et al. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the California population: evaluating matching in a multiethnic and admixed population. Stem Cells Transl Med [Internet]. 2015; 4:413\u20138. Available from: https:\/\/academic.oup.com\/stcltm\/article\/4\/5\/413-418\/6397381","DOI":"10.5966\/sctm.2015-0052"},{"key":"3182_CR12","doi-asserted-by":"crossref","unstructured":"Shin S, Song EY, Kwon Y-W, Oh S, Park H, Kim N-H, et al. Usefulness of the hematopoietic stem cell donor pool as a source of HLA-homozygous induced pluripotent stem cells for haplobanking: combined analysis of the cord blood inventory and bone marrow donor registry. Biol Blood Marrow Transplant [Internet]. 2020;26:e202\u20138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120302913","DOI":"10.1016\/j.bbmt.2020.05.008"},{"key":"3182_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-021-02301-0","volume":"12","author":"B \u00c1lvarez-Palomo","year":"2021","unstructured":"\u00c1lvarez-Palomo B, Garc\u00eda-Martinez I, Gayoso J, Raya A, Veiga A, Abad ML, et al. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells. Stem Cell Res Ther. 2021;12:4\u201311.","journal-title":"Stem Cell Res Ther"},{"key":"3182_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/stem.772","volume":"30","author":"PA Gourraud","year":"2012","unstructured":"Gourraud PA, Gilson L, Girard M, Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic \u201chaplobank\u201d of induced pluripotent stem cell lines. Stem Cells. 2012;30:180\u20136.","journal-title":"Stem Cells"},{"key":"3182_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-091212-153455","volume":"14","author":"J Trowsdale","year":"2013","unstructured":"Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet. 2013;14:301\u201323.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3182_CR16","first-page":"192","volume":"14","author":"X Zheng","year":"2014","unstructured":"Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, et al. HIBAG - HLA genotype imputation with attribute bagging. Pharmacogen J Nat Publ Group. 2014;14:192\u2013200.","journal-title":"Pharmacogen J Nat Publ Group"},{"key":"3182_CR17","doi-asserted-by":"crossref","unstructured":"Ritari J, Hyv\u00e4rinen K, Clancy J, FinnGen, Partanen J, Koskela S. Increasing accuracy of HLA imputation by a population-specific reference panel in a FinnGen biobank cohort. NAR Genomics Bioinforma 2020;2: 30.","DOI":"10.1093\/nargab\/lqaa030"},{"key":"3182_CR18","doi-asserted-by":"crossref","unstructured":"Dilthey AT, Moutsianas L, Leslie S, McVean G. HLA*IMP--an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics [Internet]. 2011\/02\/07. Oxford University Press; 2011;27:968\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21300701","DOI":"10.1093\/bioinformatics\/btr061"},{"key":"3182_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-4939-8546-3_11","volume":"1802","author":"X Zheng","year":"2018","unstructured":"Zheng X, Imputation-Based HLA. Typing with SNPs in GWAS Studies. Methods Mol Biol US. 2018;1802:163\u201376.","journal-title":"Methods Mol Biol US"},{"key":"3182_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/ng.3310","volume":"47","author":"Y Okada","year":"2015","unstructured":"Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, et al. Construction of a population-specific HLA imputation reference panel and its application to graves\u2019 disease risk in Japanese. Nat Genet US. 2015;47:798\u2013802.","journal-title":"Nat Genet US"},{"key":"3182_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/tan.12343","volume":"83","author":"E Vlachopoulou","year":"2014","unstructured":"Vlachopoulou E, Lahtela E, Wennerstr\u00f6m A, Havulinna AS, Salo P, Perola M, et al. Evaluation of HLA-DRB1 imputation using a finnish dataset. Tissue Antigens England. 2014;83:350\u20135.","journal-title":"Tissue Antigens England"},{"key":"3182_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41397-020-0156-3","volume":"20","author":"Y-H Huang","year":"2020","unstructured":"Huang Y-H, Khor S-S, Zheng X, Chen H-Y, Chang Y-H, Chu H-W, et al. A high-resolution HLA imputation system for the Taiwanese population: a study of the Taiwan biobank. Pharmacogen J US. 2020;20:695\u2013704.","journal-title":"Pharmacogen J US"},{"key":"3182_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajhg.2007.09.001","volume":"82","author":"S Leslie","year":"2008","unstructured":"Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet. 2008;82:48\u201356.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3182_CR24","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1537-2995.2010.02812.x","volume":"50","author":"R Mitchell","year":"2010","unstructured":"Mitchell R. Blood banks biobanks and the ethics of donation. Transfusion. 2010;50(9):1866\u201399. https:\/\/doi.org\/10.1111\/j.1537-2995.2010.02812.x.","journal-title":"Transfusion"},{"key":"3182_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41431-019-0434-1","volume":"27","author":"V Raivola","year":"2019","unstructured":"Raivola V, Snell K, Helen I, Partanen J. Attitudes of blood donors to their sample and data donation for biobanking. Eur J Hum Genet. 2019;27:1659\u201367.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"3182_CR26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/trf.14596","volume":"58","author":"V Raivola","year":"2018","unstructured":"Raivola V, Snell K, Pastila S, Hel\u00e9n I, Partanen J. Blood donors\u2019 preferences for blood donation for biomedical research. Transfusion. 2018;58(7):1640.","journal-title":"Transfusion"},{"key":"3182_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood.V51.5.903.903","volume":"51","author":"J Gmur","year":"1978","unstructured":"Gmur J, von Felten A, Frick P. Platelet support in polysensitized patients: role of HLA specificities and crossmatch testing for donor selection. Blood. 1978;51:903\u20139.","journal-title":"Blood"},{"key":"3182_CR28","unstructured":"18th international HLA & immunogenetics workshop [Internet]. [cited 2022 Feb 18]. Available from: https:\/\/www.ihiw18.org\/component-immunogenetics\/creating-fully-representative-mhc-reference-haplotypes\/"},{"key":"3182_CR29","doi-asserted-by":"crossref","unstructured":"Feola S, Chiaro J, Martins B, Cerullo V. Uncovering the tumor antigen landscape: what to know about the discovery process. Cancers (Basel) [Internet]. 2020;12:1660. Available from: https:\/\/www.mdpi.com\/2072-6694\/12\/6\/1660","DOI":"10.3390\/cancers12061660"},{"key":"3182_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbmt.2017.10.010","volume":"24","author":"T Linjama","year":"2018","unstructured":"Linjama T, Eberhard H-P, Per\u00e4saari J, M\u00fcller C, Korhonen M. A European HLA Isolate and Its Implications for hematopoietic stem cell transplant donor procurement. Biol Blood Marrow Trans. 2018;24:587\u201393.","journal-title":"Biol Blood Marrow Trans"},{"key":"3182_CR31","unstructured":"FinnGen R4 Gitbook [Internet]. [cited 2022 Feb 18]. Available from: https:\/\/finngen.gitbook.io\/documentation\/v\/r4\/"},{"key":"3182_CR32","unstructured":"R script for allele frequency calculation [Internet]. [cited 2022 Feb 27]. Available from: https:\/\/www.molecularecologist.com\/wp-content\/uploads\/2012\/03\/Allelefrequency_calculations2.txt"},{"key":"3182_CR33","unstructured":"IPD-IMGT\/HLA Database [Internet]. [cited 2022 Feb 18]. Available from: https:\/\/www.ebi.ac.uk\/ipd\/imgt\/hla\/"},{"key":"3182_CR34","doi-asserted-by":"crossref","unstructured":"Haimila K, Perasaari J, Linjama T, Koskela S, Saarinenl T, Lauronen J, et al. HLA antigen, allele and haplotype frequencies and their use in virtual panel reactive antigen calculations in the Finnish population. Tissue Antigens. Clinical Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland. katri.haimila@bts.redcross.fi: John Wiley & Sons A\/S; 2013;81:35\u201343.","DOI":"10.1111\/tan.12036"},{"key":"3182_CR35","unstructured":"R Core Team [Internet]. Available from: https:\/\/www.r-project.org\/"},{"key":"3182_CR36","unstructured":"R studio [Internet]. Available from: https:\/\/www.rstudio.com\/"},{"key":"3182_CR37","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.bbmt.2019.07.008","volume":"25","author":"T Linjama","year":"2019","unstructured":"Linjama T, R\u00e4ther C, Ritari J, Per\u00e4saari J, Eberhard H-P, Korhonen M, et al. Extended HLA haplotypes and their impact on DPB1 matching of unrelated hematologic stem cell transplant donors. Biol Blood Marrow Transplant [Internet]. 2019;25:1956\u201364.","journal-title":"Biol Blood Marrow Transplant [Internet]."},{"key":"3182_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bjh.13597","volume":"171","author":"SJ Stanworth","year":"2015","unstructured":"Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness - practical approaches and ongoing dilemmas in patient management. Br J Haematol [Internet]. 2015;171:297\u2013305. https:\/\/doi.org\/10.1111\/bjh.13597.","journal-title":"Br J Haematol [Internet]."},{"key":"3182_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/trf.15108","volume":"59","author":"C Karlstr\u00f6m","year":"2019","unstructured":"Karlstr\u00f6m C, Linjama T, Edgren G, Lauronen J, Wikman A, H\u00f6glund P. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience. Transfusion [Internet]. 2019;59:945\u201352. https:\/\/doi.org\/10.1111\/trf.15108.","journal-title":"Transfusion [Internet]."},{"key":"3182_CR40","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/bloodadvances.2020001894","volume":"4","author":"NS Gleadall","year":"2020","unstructured":"Gleadall NS, Veldhuisen B, Gollub J, Butterworth AS, Ord J, Penkett CJ, et al. Development and validation of a universal blood donor genotyping platform: a multinational prospective study. Blood Adv [Internet]. 2020;4:3495\u2013506.","journal-title":"Blood Adv [Internet]."},{"key":"3182_CR41","unstructured":"18th [Internet]. [cited 2022 Feb 18]. Available from: https:\/\/www.ihiw18.org\/component-immunogenetics\/creating-fully-representative-mhc-reference-haplotypes\/"},{"key":"3182_CR42","doi-asserted-by":"crossref","unstructured":"Kere J. Human population genetics: lessons from Finland. Annu Rev Genomics Hum Genet. Finnish Genome Center, University of Helsinki, Helsinki 00014, Finland. juha.kere@helsinki.fi; 2001;2:103\u201328.","DOI":"10.1146\/annurev.genom.2.1.103"},{"key":"3182_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00439-002-0876-2","volume":"112","author":"R Norio","year":"2003","unstructured":"Norio R. Finnish disease heritage II: population prehistory and genetic roots of Finns. Hum Genet. 2003;112:457\u201369.","journal-title":"Hum Genet"},{"key":"3182_CR44","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1073\/pnas.93.21.12035","volume":"93","author":"A Sajantila","year":"1996","unstructured":"Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Paabo S. Paternal and maternal DNA lineages reveal a bottleneck in the founding of the finnish population. Proc Natl Acad Sci [Internet]. 1996;93:12035\u20139. https:\/\/doi.org\/10.1073\/pnas.93.21.12035.","journal-title":"Proc Natl Acad Sci [Internet]"},{"key":"3182_CR45","doi-asserted-by":"crossref","unstructured":"Kerminen S, Havulinna AS, Hellenthal G, Martin AR, Sarin A-P, Perola M, et al. Fine-scale genetic structure in Finland. G3 Genes|Genomes|Genetics [Internet]. 2017;7:3459\u201368. Available from: https:\/\/academic.oup.com\/g3journal\/article\/7\/10\/3459\/6027487","DOI":"10.1534\/g3.117.300217"},{"key":"3182_CR46","doi-asserted-by":"crossref","unstructured":"Siren MK, Sareneva H, Lokki ML, Koskimies S. Unique HLA antigen frequencies in the finnish population. Tissue Antigens. Finnish Bone Marrow Donor Registry, Finnish Red Cross Blood Transfusion Service, Helsinki, Finland.; 1996;48:703\u20137.","DOI":"10.1111\/j.1399-0039.1996.tb02695.x"},{"key":"3182_CR47","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","volume":"74","author":"L Gragert","year":"2013","unstructured":"Gragert L, Madbouly A, Freeman J, Maiers M. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol [Internet]. 2013;74:1313\u201320.","journal-title":"Hum Immunol [Internet]."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03182-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T18:03:41Z","timestamp":1665338621000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03182-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1465643\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,9]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of the genotype data is in accordance with the biobank consent and meets the requirements of the Finnish Biobank Act 688\/2012. A formal biobank decision 002-2018 for the use of the genotype data has been granted for the research project by the Finnish Red Cross Blood Service Biobank.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"502"}}